|
1W80
Crystal structure of the alpha-adaptin appendage domain, from the AP2 adaptor complex, bound to 2 peptides from Synaptojanin170
Deposited 2004-09-14
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain P
1479–1490(12 aa)
Fragment:PEPTIDE CONTAINING WVXF MOTIF, RESIDUES 1479-1490
Chain Q
1460–1471(12 aa)
Fragment:PEPTIDE CONTAINING FXDXF MOTIF, RESIDUES 1460-1471
|
Not recorded
|
BEN BENZAMIDINE × 1
CO3 CARBONATE ION × 3
DTD DITHIANE DIOL × 1
SO4 SULFATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6.5;1.2M AMMONIUM SULFATE, 3% ISOPROPANOL, 0.05M SODIUM CITRATE, pH 6.50
|
Resolution 1.90 Å
R-free 0.224
|
|
2DNR
Solution structure of RNA binding domain in Synaptojanin 1
Deposited 2006-04-26
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
894–971(78 aa)
Fragment:RNA recognition motif
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 7;298 K;Ionic strength (raw mmCIF value) 120mM;Pressure ambient
NMR sample composition
1.11mM 13C-15N PROTEIN, 20mM d-Tris-HCl(pH7.0), 100mM NaCl, 1mM d-DTT, 0.02% NaN3, 90% H2O, 10% D2O | 90% H2O/10% D2O
|
Resolution not provided
|
|
2VJ0
Crystal structure of the alpha-adaptin appendage domain, from the AP2 adaptor complex, in complex with an FXDNF peptide from amphiphysin1 and a WVXF peptide from synaptojanin P170
Deposited 2007-12-06
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain P
1479–1490(12 aa)
Fragment:PEPTIDE CONTAINING WVXF MOTIF, RESIDUES 1479-1490
|
Not recorded
|
BEN BENZAMIDINE × 1
DTD DITHIANE DIOL × 1
SO4 SULFATE ION × 3
CL CHLORIDE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6.5;1.2M AMMONIUM SULPHATE, 3% ISOPROPANOL AND 0.05M SODIUM CITRATE PH 6.5
|
Resolution 1.60 Å
R-free 0.208
|
|
7A17
Crystal structure of the 5-phosphatase domain of Synaptojanin1 bound to its substrate diC8-PI(3,4,5)P3 in complex with a nanobody
Deposited 2020-08-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
528–873(346 aa)
|
Not recorded
|
IP9 (2R)-3-{[(R)-{[(1S,2S,3R,4S,5S,6S)-2,6-dihydroxy-3,4,5-tris(phosphonooxy)cyclohexyl]oxy}(hydroxy)phosphoryl]oxy}propane -1,2-diyl dioctanoate × 1
MG MAGNESIUM ION × 1
GOL GLYCEROL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5.5;293 K;15% PEG 3350, 0.1 M sodium citrate pH 5.5, 13% ethanol
|
Resolution 2.73 Å
R-free 0.257
|
|
7A17
Crystal structure of the 5-phosphatase domain of Synaptojanin1 bound to its substrate diC8-PI(3,4,5)P3 in complex with a nanobody
Deposited 2020-08-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain C
529–873(345 aa)
|
Not recorded
|
MG MAGNESIUM ION × 1
PO4 PHOSPHATE ION × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5.5;293 K;15% PEG 3350, 0.1 M sodium citrate pH 5.5, 13% ethanol
|
Resolution 2.73 Å
R-free 0.257
|
|
7A17
Crystal structure of the 5-phosphatase domain of Synaptojanin1 bound to its substrate diC8-PI(3,4,5)P3 in complex with a nanobody
Deposited 2020-08-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain E
529–873(345 aa)
|
Not recorded
|
PO4 PHOSPHATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5.5;293 K;15% PEG 3350, 0.1 M sodium citrate pH 5.5, 13% ethanol
|
Resolution 2.73 Å
R-free 0.257
|